PrimaryMarkets

VIEW OUR WEBINARS

eGrowcery Part 3 - eGrowcery Difference, Financials and Q&A
eGrowcery Part 3 - eGrowcery Difference, Financials and Q&A
View Recording

eGrowcery Part 2 - Industry Overview, Channel Fragmentation & Competitive Analysis
eGrowcery Part 2 - Industry Overview, Channel Fragmentation & Competitive Analysis
View Recording

eGrowcery Part 1 - Company and Business Overview
eGrowcery Part 1 - Company and Business Overview
View Recording

SOFI Spritz - Australia’s Aperitivo
SOFI Spritz - Australia’s Aperitivo
View Recording

Deal Snapshot
Deal Snapshot
View Recording

Biopharmaceutical Company founded by Australian Nobel Laureate - Patented Product for Treatments of Allergy Indications

Categories Securities, Unissued Securities
Sale Type Price on Application
Price Guide AUD A$3.5M raise at A$0.05 per share - A$2.75M already raised (pre-money valuation of A$1.57M)
Status: Closed

Summary:

Unlisted Australian company founded by Australian Nobel Laureate to develop and commercialise novel treatments in rapidly growing international market for allergic indications including childhood eczema, food allergies, allergic asthma. Funds required to complete pre-clinical studies and quality manufacture of patented product for use in animal safety studies and clinical trials.

 

 

Share this Listing

 

Go Back

Become a Follower